How to Scale Genomics to Transform Precision Diagnostics

How to Scale Genomics to Transform Precision Diagnostics

Kengo Takishima, Chairman and CEO of Baylor Genetics, discusses how collaboration across the healthcare system, broader multiomic approaches, and strong operational integration into routine clinical care are key to improving patient care.

“For innovation to truly scale, it will require deep collaboration and seamless integration across the healthcare ecosystem,” said Kengo Takishima.

Read the full byline on Fast Company’s website.